Experienced in Peripheral Neuropathy

Douglas W. Zochodne

Edmonton, AB, CA 
Experienced in Peripheral Neuropathy
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Douglas Zochodne practices in Edmonton, Canada. Mr. Zochodne is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Diabetic Neuropathy, Wallerian Degeneration, Sensorimotor Polyneuropathy, and Mononeuritis Multiplex.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Peripheral Neuropathy.

Gender
Male

Locations

Edmonton, AB, Canada
Other Locations
Calgary, AB, Canada
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Parallel, 24-Week, Phase 2a Study of Topical Pirenzepine (WST-057) or Placebo in Type 2 Diabetic Patients With Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Drug: WST-057 Pirenzepine Free Base Monohydrate
Study Phase: Phase 2
View 1 Less Clinical Trial

109 Total Publications

Reversible rituximab demyelination in anti-MAG polyneuropathy: A role for IVIG?
Reversible rituximab demyelination in anti-MAG polyneuropathy: A role for IVIG?
Journal: Journal of the neurological sciences
Published: May 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zochodne's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile